Two Sigma Securities’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-5,530
Closed -$15.3K – 2133
2025
Q4
$15.3K Buy
+5,530
New +$33.1K ﹤0.01% 1224
2025
Q1
– Sell
-101
Closed -$2.59K – 2100
2024
Q4
$2.59K Sell
101
-48
-32% -$1.59K ﹤0.01% 1498
2024
Q3
$6K Buy
149
+69
+86% +$3.48K ﹤0.01% 2658
2024
Q2
$2.96K Buy
80
+14
+21% +$656 ﹤0.01% 2876
2024
Q1
$4.85K Sell
66
-123
-65% -$9.8K ﹤0.01% 2841
2023
Q4
$16.7K Buy
+189
New +$18K ﹤0.01% 2750
2023
Q3
– Sell
-226
Closed -$40.4K – 3407
2023
Q2
$40.4K Buy
+226
New +$41.3K ﹤0.01% 2424
2022
Q1
– Sell
-102
Closed -$19K – 2452
2021
Q4
$19K Buy
+102
New +$27.6K ﹤0.01% 1414

Other funds holding EDVA

Two Sigma Securities's EDVA Position: Q1 2026 in Review

Two Sigma Securities sold out of Endovia Health Sciences, Inc. (EDVA) in Q1 2026, closing a stake of 5,530 shares — an estimated $15.3K sold.

Two Sigma Securities first reported a position in EDVA in Q4 2021 and held it in 8 quarters. The position peaked at $40.4K in Q2 2023. 15 funds tracked by Wall St. Rank hold EDVA as of Q1 2026.

  • Two Sigma Securities reported no remaining Endovia Health Sciences, Inc. position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 5,530 Endovia Health Sciences, Inc. shares in Q1 2026, an estimated $15.3K.
  • Two Sigma Securities first reported a position in Endovia Health Sciences, Inc. in Q4 2021 and held it in 8 quarters.
  • Two Sigma Securities's Endovia Health Sciences, Inc. position peaked at $40.4K in Q2 2023.
  • 15 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.